Published in Vopr Revm on August 27, 1981
Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol (1998) 0.96
Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol (2008) 0.92
[A novel immunoregulating hexapeptide with antineoplastic effect]. Vopr Onkol (2001) 0.87
Molecular pathogenesis of systemic lupus erythematosus. Arch Virol (1975) 0.85
Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol Lett (2002) 0.85
DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases. FEBS Lett (1992) 0.83
Endocarditis with left atrial thrombus formation in Behçet's disease mimicking myxoma. J Rheumatol (1993) 0.82
[Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.81
[The antiviral activity of RNAse Bacillus intermedius in experiments with mice preinfected with street rabies virus]. Vopr Virusol (2004) 0.81
[Antiviral activity of Bacillus intermedius RNAase in guinea-pigs and rabbits infected with outdoor rabies virus]. Vopr Virusol (2006) 0.81
[Preparation of monoclonal antibodies to super early human cytomegalovirus proteins and their use for detecting infected cells]. Vopr Virusol (1996) 0.79
[Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus]. Ter Arkh (1980) 0.79
[The HLA-B5 immunogenetic marker in Behçet's disease]. Ter Arkh (1993) 0.78
[Clinical significance of determining antibodies to poly A: poly U in systemic lupus erythematosus]. Ter Arkh (1972) 0.78
[Catalytic autoantibodies--a new molecular instrument in cardiology and ophthalmology]. Ter Arkh (2006) 0.78
[Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus]. Klin Med (Mosk) (2003) 0.78
[Characteristics of retinal vascular involvement in systemic lupus erythematosus]. Vestn Oftalmol (2001) 0.78
[Synthesis and antitumor activity of cyclopropane derivatives of betulinic and betulonic acids]. Bioorg Khim (2005) 0.78
[Behçet's disease: clinical and demographic associations]. Ter Arkh (2013) 0.77
Synergistic antiproliferative effect of cis-diammine-dichloroplatinum (II) and a new anticancer agent, plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C. Biomed Sci (1991) 0.77
[Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases]. Vestn Oftalmol (2002) 0.77
[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77
[The role of estrogen-androgen imbalance in rheumatic diseases]. Ter Arkh (1990) 0.76
[DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance]. Ter Arkh (2005) 0.76
[Abortive and recurrent rabies in dogs intracerebrally infected with the rabies street virus]. Vopr Virusol (1989) 0.76
[Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Klin Med (Mosk) (1998) 0.76
Endothelial inclusions and "nuclear bodies" in systemic lupus erythematosus. Ann Rheum Dis (1973) 0.75
[Antigenic relations of the rabies group viruses studied in the blast transformation and immunofluorescence tests]. Vopr Virusol (1979) 0.75
[Continuous lymphoblastoid cell lines in virological research]. Vopr Virusol (1981) 0.75
[Study of precipitating antibodies in children with Botkin's disease]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[Epidemiologic and cytogenetic studies on detecting carriers of the Botkin's disease virus among donors]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Combined action of a specific vaccine, exogenous interferon and an interferon inducer on the development of acute experimental encephalomyelitis]. Vopr Virusol (1983) 0.75
[Effectiveness of dsRNA as an interferon inducer in the intramuscular infection of mice with rabies street virus]. Vopr Virusol (1983) 0.75
[Antigens associated with herpes simplex viruses in human and animal tumors]. Vopr Virusol (1984) 0.75
[Successful results in the interferon therapy of autoimmune disease in NZB/W strain mice]. Vopr Virusol (1984) 0.75
[Etiology and pathogenesis of chronic viral hepatitis and liver cirrhosis]. Sov Med (1972) 0.75
[Effect of the interferon inducer double-stranded RNA on the development of vaccinal antirabies immunity]. Vopr Virusol (1984) 0.75
[Comparative experimental studies of the combined use of vaccines, interferon and interferon inducers in neurovirus infections]. Vopr Virusol (1979) 0.75
[Immunomorphological studies of the leukocytes in schizophrenia]. Vopr Virusol (1972) 0.75
[Damage to the chromosomes in various viral infections]. Vopr Virusol (1969) 0.75
[Formation of DNA-proviruses in cells of a human transplantable lymphoid line during infection with tick-borne encephalitis viruses or measles virus]. Dokl Akad Nauk SSSR (1978) 0.75
[Metacentric chromosomes in the karyotype of spleen lines of BALB/c mice, chronically infected with Friend and Rauscher leukemia viruses]. Vopr Virusol (1975) 0.75
[Mutual stimulation of oncornavirus and herpetic infections in experiments in vivo and in vitro]. Vopr Virusol (1977) 0.75
[Cellular immunity study of multiple sclerosis in the lymphocyte blast transformation reaction to the viruses of acute human encephalomyelitis, herpes and measles]. Vopr Virusol (1983) 0.75
[Australia antigen in patients with glomerulonephritis]. Klin Med (Mosk) (1984) 0.75
[Interferon formation in viral hepatitis and liver cirrhosis of viral etiology]. Sov Med (1974) 0.75
[Hepatitis B antigen and its determinants in viral hepatitis in children]. Pediatriia (1977) 0.75
[Prophylactic and therapeutic activity of an interferon inducer in mice infected intracerebrally with rabies street virus]. Vopr Virusol (1983) 0.75
[Immunofluorescent method of detecting viremia in postvaccinal complications]. Vopr Virusol (1983) 0.75
[Viruses of the rabies group]. Vopr Virusol (1980) 0.75
[Virus-induced antigen in cells infected with the herpes simplex virus]. Vopr Virusol (1981) 0.75
[Reproduction of various viruses in leukocyte cultures]. Vopr Virusol (1968) 0.75
[Biological variants of a population of strains of the rabies street virus]. Vopr Virusol (1983) 0.75
[A leukocyte virus in human hepatitis]. Vopr Virusol (1971) 0.75
[An electron microscope study of monolayer leukocyte cultures from viral hepatitis patients]. Vopr Virusol (1972) 0.75
[Therapeutic activity of the combined use of an interferon inducer and vaccine in experimental rabies]. Vopr Virusol (1984) 0.75
[Study of HB-Ag subtypes in patients with viral hepatitis and in donors with antigenemia in a number of cities of the USSR]. Sov Med (1975) 0.75
[Further study of the leukocyte virus isolated in hepatitis A]. Vopr Virusol (1979) 0.75
[Virologic studies in systemic lupus erythematosus]. Vestn Akad Med Nauk SSSR (1977) 0.75
[Viremia in genital herpes]. Vestn Dermatol Venerol (1982) 0.75
[Resistance of various herpes simplex virus strains to the action of chemical inhibitors]. Vopr Virusol (1983) 0.75
[Transplantable lines of mouse spleen cells infected with Friend and Rauscher leukemia viruses]. Vopr Virusol (1973) 0.75
[Virus-like particles in the sera of patients with viral hepatitis and donors with antigenemia]. Vopr Virusol (1978) 0.75
[Effect of cyclophosphane on the development of experimental chronic herpetic infection in animals]. Vopr Virusol (1977) 0.75
[Use of the iodine test for the purpose of detection of hypergammaglobulinemia in chronic viral hepatitis and other chronic infections]. Lab Delo (1975) 0.75
[Isolation of herpes simplex virus in chronic meningoencephalitis]. Vopr Virusol (1981) 0.75
[Immunostimulating effect of interferon inducers]. Vopr Virusol (1983) 0.75
[Inhibiting effect of cholera vibrio neuraminidase in Rauscher mouse leukemia]. Biull Eksp Biol Med (1976) 0.75
[Adoptive immunity test in the study of immunogenesis of the vaccination process in tick-borne encephalitis and herpes]. Vopr Virusol (1983) 0.75
[Herpetic pathology and current methods of treating herpetic lesions]. Sov Med (1983) 0.75
[Morphological and immunofluorescent studies of the leukocytes in blood smears in hepatitis A and B and chronic liver diseases]. Vopr Virusol (1979) 0.75
[Immunofluorescent study of blood smears from children in viral hepatitis foci]. Pediatriia (1980) 0.75
[Experimental study of viremia in immune host in tick-borne encephalitis]. Vopr Virusol (1980) 0.75
[Effect of immunostimulants on the intensity of vaccinal antirabies immunity]. Vopr Virusol (1985) 0.75
[Viral hepatitis in man and animals]. Vopr Virusol (1969) 0.75
[Vaccine and poludan in experimental and clinical herpes simplex]. Vestn Dermatol Venerol (1984) 0.75
[Use of leukocyte cultures for detecting viruses in human leukemia]. Vopr Virusol (1974) 0.75
[Virological aspects of the use of the phenomenon of lymphocyte blast transformation in vitro]. Vopr Virusol (1972) 0.75
[The agar gel precipitation test in infectious hepatitis]. Sov Med (1969) 0.75
[Pathomorphology of abortive rabies]. Vopr Virusol (1981) 0.75
[Blood leukocyte culture and its use in studying the etiology of Botkin's viral hepatitis]. Sov Med (1969) 0.75
[Comparative results from the use of the direct immunoperoxidase and immunofluorescence methods to diagnose chronic herpetic infection]. Vopr Virusol (1980) 0.75
[alpha-Interferon indices in systemic lupus erythematosus and the effect of interferon therapy]. Vopr Virusol (1984) 0.75
[Combined use of a specific vaccine and interferon inducers for preventing and treating experimental tick-borne encephalitis]. Vopr Virusol (1984) 0.75
[Comparative evaluation of several methods of diagnosing hepatitis A]. Vopr Virusol (1981) 0.75
[Botkin's viral hepatitis and the problem of the Australia antigen]. Sov Med (1973) 0.75
[Mechanism of action of inactivated herpes vaccine in rabbits with chronic herpetic infections]. Vopr Virusol (1978) 0.75
[Etiopathogenesis of chronic viral infections]. Vestn Akad Med Nauk SSSR (1972) 0.75
[Genital herpes and cervical cancer]. Vopr Virusol (1984) 0.75
[New developments in the study of virusemia]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Specificity of the human "leukocytic virus of leukemia"]. Vopr Virusol (1977) 0.75
[Efficacy of herpetic polyvaccine in patients with recurrent herpes (late results)]. Vestn Dermatol Venerol (1982) 0.75
[Detection of hepatitis A and B markers in the bone marrow of patients with chronic active hepatitis]. Vestn Akad Med Nauk SSSR (1980) 0.75
[Means of producing rabbit immune antiherpes serum]. Vopr Virusol (1979) 0.75
[Nonspecific indices of cellular and humoral immunity in viral hepatitis A and B patients]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Properties of herpes simplex virus strains isolated from patients with recurrent cutaneous herpes]. Vopr Virusol (1985) 0.75
[Experience in the use of the immunofluorescence method in the complex diagnosis of epidemic hepatitis]. Sov Med (1968) 0.75
[Possibility of transferring the causative agent from blood serum of patients with Botkin's virus hepatitis to a leukocyte culture of blood from healthy donors]. Biull Eksp Biol Med (1969) 0.75